BCM
CLMT icon

Bluefin Capital Management’s Calumet Specialty Products CLMT Stock Holding History

Bluefin Capital Management’s Portfolio CLMT Stock Details CLMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-156,108
Closed -$2.06M – 713
2021
Q4 		$2.06M Buy
+156,108
New +$1.96M 0.14% 120
2013
Q4 		– Sell
-6,550
Closed -$200K – 341
2013
Q3 		$200K Sell
6,550
-800
-11% -$25.1K 0.02% 348
2013
Q2 		$300K Buy
+7,350
New +$264K 0.03% 375

Other funds holding CLMT

AAA
Adams Asset Advisors Dallas, Texas $882M AUM 42% 1-Year Est. Return
DMKJ
David M. Knott Jr $168M AUM 60.36% 1-Year Est. Return
EGA
Evermore Global Advisors Summit, New Jersey $26.3M AUM 7.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $33.7B AUM 35.49% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
BC
Barnett & Company Chattanooga, Tennessee $129M AUM 14.9% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bluefin Capital Management's CLMT Position: Q1 2022 in Review

Bluefin Capital Management sold out of Calumet Specialty Products (CLMT) in Q1 2022, closing a stake of 156,108 shares — an estimated $2.06M sold.

Bluefin Capital Management first reported a position in CLMT in Q2 2013 and held it in 3 quarters. The position peaked at $2.06M in Q4 2021. 61 funds tracked by Wall St. Rank hold CLMT as of Q1 2022.

  • Bluefin Capital Management reported no remaining Calumet Specialty Products position as of Q1 2022 after selling out during the quarter.
  • Bluefin Capital Management sold 156,108 Calumet Specialty Products shares in Q1 2022, an estimated $2.06M.
  • Bluefin Capital Management first reported a position in Calumet Specialty Products in Q2 2013 and held it in 3 quarters.
  • Bluefin Capital Management's Calumet Specialty Products position peaked at $2.06M in Q4 2021.
  • 61 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q1 2022.

Based on Bluefin Capital Management's 13F filing for Q1 2022, filed 16 May 2022.